EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study

Shirkhan Amikishiyev iD, Yasemin Yalçınkaya, Konul Mammadova, Numune Aliyeva, Gorkem Durak, Bahar Artim-Esen, Ahmet Gül, Ahmet Kaya Bilge, Gulfer Okumuş, Murat Inanc

Modern Rheumatology · 2025

DOI: 10.1093/mr/roae095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Shirkhan Amikishiyev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Lung Diseases, Interstitial, Hypertension, Pulmonary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We aimed to investigate mortality and prognostic factors in systemic sclerosis (SSc) patients with pulmonary hypertension (PH) with or without interstitial lung disease (ILD).

Methods

The associations between mortality and demographics, transthoracic echocardiography, right heart catheterization (RHC), pulmonary functional parameters at baseline, and treatment modalities were evaluated.

Results

Survival rates for PH-SSc patients (42 female, mean age 56.6 ± 13.5, median follow-up 45 months) were 91% at the first year, 75% at 2 years, and 43.1% at 5 years. The majority of the deceased patients had PH + ILD (P = .007). The PH + ILD group had more diffuse skin involvement, anti-Scl-70, high C-reactive protein, low FVC, and lower DLCO. The deceased patients had higher estimated pulmonary arterial systolic pressure (PASP), low cardiac output, and FVC values. Median survival time was significantly better in patients on combined therapy. Mortality-related factors in the PH + ILD group were decreased initial FVC, high estimated PASP, low cardiac output, deteriorated functional class, and monotherapy.

Conclusion

This is the first reported SSc-PH cohort from Turkey by a multidisciplinary team. PH is a severe complication of SSc with high mortality especially in patients with accompanying severe ILD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicLung Diseases, InterstitialHypertension, PulmonaryHumansFemaleMiddle AgedMaleFollow-Up StudiesAgedAdultPrognosisSurvival RateEchocardiographyTurkey

Stichwörter der Autor:innen

PAH-specific therapySystemic sclerosisinterstitial lung diseasepulmonary function testspulmonary hypertension

Autor:innen und Institutionen

  • Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey.
  • Department of Chest Diseases, Istanbul Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey.
  • Department of Radiology, İstanbul Faculty of Medicine, İstanbul University, Fatih, Istanbul, Turkey.
  • Department of Cardiology, İstanbul Faculty of Medicine, İstanbul University, Fatih, Istanbul, Turkey.

ORCID-Profile: Shirkhan Amikishiyev

Zitieren

APA

Amikishiyev, S., Yalçınkaya, Y., Mammadova, K., Aliyeva, N., Durak, G., Artim-Esen, B., Gül, A., Bilge, A. K., Okumuş, G., & Inanc, M. (2025). Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study. Modern Rheumatology. https://doi.org/10.1093/mr/roae095

Vancouver

Amikishiyev S, Yalçınkaya Y, Mammadova K, Aliyeva N, Durak G, Artim-Esen B, et al. Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study. Modern Rheumatology. 2025. doi:10.1093/mr/roae095

BibTeX
@article{Amikishiyev2025,
  author = {Amikishiyev, Shirkhan and Yalçınkaya, Yasemin and Mammadova, Konul and Aliyeva, Numune and Durak, Gorkem and Artim-Esen, Bahar and Gül, Ahmet and Bilge, Ahmet Kaya and Okumuş, Gulfer and Inanc, Murat},
  title = {Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study},
  journal = {Modern Rheumatology},
  year = {2025},
  doi = {10.1093/mr/roae095}
}
Kostenlos starten →